Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2036337
Max Phase: Preclinical
Molecular Formula: C25H28O7S
Molecular Weight: 472.56
Molecule Type: Small molecule
Associated Items:
ID: ALA2036337
Max Phase: Preclinical
Molecular Formula: C25H28O7S
Molecular Weight: 472.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(/C=C2\CSC/C(=C\c3cc(OC)c(OC)c(OC)c3)C2=O)cc(OC)c1OC
Standard InChI: InChI=1S/C25H28O7S/c1-27-19-9-15(10-20(28-2)24(19)31-5)7-17-13-33-14-18(23(17)26)8-16-11-21(29-3)25(32-6)22(12-16)30-4/h7-12H,13-14H2,1-6H3/b17-7+,18-8+
Standard InChI Key: AKXBYDPKCCRYOP-ZEELXFFVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 472.56 | Molecular Weight (Monoisotopic): 472.1556 | AlogP: 4.52 | #Rotatable Bonds: 8 |
Polar Surface Area: 72.45 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.16 | CX LogD: 4.16 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.52 | Np Likeness Score: -0.05 |
1. Wei X, Du ZY, Zheng X, Cui XX, Conney AH, Zhang K.. (2012) Synthesis and evaluation of curcumin-related compounds for anticancer activity., 53 [PMID:22551677] [10.1016/j.ejmech.2012.04.005] |
2. Tan KL, Ali A, Du Y, Fu H, Jin HX, Chin TM, Khan M, Go ML.. (2014) Synthesis and evaluation of bisbenzylidenedioxotetrahydrothiopranones as activators of endoplasmic reticulum (ER) stress signaling pathways and apoptotic cell death in acute promyelocytic leukemic cells., 57 (14): [PMID:24960549] [10.1021/jm401352a] |
3. Zhang Y, Liu Z, Wu J, Bai B, Chen H, Xiao Z, Chen L, Zhao Y, Lum H, Wang Y, Zhang H, Liang G.. (2018) New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity., 148 [PMID:29466778] [10.1016/j.ejmech.2018.02.008] |
Source(1):